
Ep139: Kevin Conroy on Early Detection of Cancer
The Long Run with Luke Timmerman
Cologard: A Commercial Launch
CMS did a deep analysis in parallel with FDA. And CMS looked at that and I mean, did its own analysis and thought based on the data, that's something we can pay for. They did. So having that national coverage decision and then a few months later pricing allowed us to launch cologard," he says. "We quickly shifted our whole mindset to a commercial launch"
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.